Top five OSN headlines in March

Live meeting coverage from the Wills Eye Conference and American Glaucoma Society meeting, along with breaking business news, were the most popular articles on Healio.com/OSN in March.

Here are the top five most-read articles for the month:

 

Prefilled anti-VEGF injection may reduce risk of endophthalmitis

Mounting evidence from an ongoing multicenter collaboration demonstrates that anti-VEGF injection via prefilled syringe may substantially reduce the risk of endophthalmitis compared with the conventional method of injection, Philip Storey, MD, MPH, said at the Wills Eye Conference. Read more.

 

SightLife Surgical acquires Kamra inlay

The Kamra is the first FDA-approved inlay for the surgical correction of presbyopia. Read more.

 

Patients regain sight after treatment with retinal tissue from stem cells

Patients with sudden severe sight loss from wet AMD have regained reading vision after being implanted with an engineered patch of retinal pigment epithelium cells derived from stem cells. Read more.

 

Insurance coverage of Vyzulta expands with Express Scripts

Vyzulta (latanoprostene bunod ophthalmic solution 0.024%, Bausch + Lomb), indicated for reducing IOP in patients with open-angle glaucoma or ocular hypertension, will be covered under an access position on the commercial Express Scripts National Preferred and Basic formularies. Read more.

 

Early follow-up after Xen implantation needed

Nearly 80% of patients who received a Xen gel stent with IOP-lowering topical medication after surgery experienced an IOP of less than 18 mm Hg, but early interventions were needed in 20% of patients, according to a speaker at the American Glaucoma Society meeting. Read more.

Live meeting coverage from the Wills Eye Conference and American Glaucoma Society meeting, along with breaking business news, were the most popular articles on Healio.com/OSN in March.

Here are the top five most-read articles for the month:

 

Prefilled anti-VEGF injection may reduce risk of endophthalmitis

Mounting evidence from an ongoing multicenter collaboration demonstrates that anti-VEGF injection via prefilled syringe may substantially reduce the risk of endophthalmitis compared with the conventional method of injection, Philip Storey, MD, MPH, said at the Wills Eye Conference. Read more.

 

SightLife Surgical acquires Kamra inlay

The Kamra is the first FDA-approved inlay for the surgical correction of presbyopia. Read more.

 

Patients regain sight after treatment with retinal tissue from stem cells

Patients with sudden severe sight loss from wet AMD have regained reading vision after being implanted with an engineered patch of retinal pigment epithelium cells derived from stem cells. Read more.

 

Insurance coverage of Vyzulta expands with Express Scripts

Vyzulta (latanoprostene bunod ophthalmic solution 0.024%, Bausch + Lomb), indicated for reducing IOP in patients with open-angle glaucoma or ocular hypertension, will be covered under an access position on the commercial Express Scripts National Preferred and Basic formularies. Read more.

 

Early follow-up after Xen implantation needed

Nearly 80% of patients who received a Xen gel stent with IOP-lowering topical medication after surgery experienced an IOP of less than 18 mm Hg, but early interventions were needed in 20% of patients, according to a speaker at the American Glaucoma Society meeting. Read more.